Stimulatory Effects of the Flavanol (-)-Epicatechin on Cardiac Angiogenesis: Additive Effects With Exercise

Abstract: The consumption of moderate amounts of cocoa products has been associated with reductions in the incidence of cardiovascular diseases. In animal studies, the flavanol (-)-epicatechin (Epi) yields cardioprotection. The effects may be partly due to its capacity to stimulate endothelial nitric oxide synthase (eNOS). The sustained activation of eNOS, as observed with exercise, can serve as a trigger of muscle angiogenesis via the activation of vascular endothelial growth factor (VEGF)–related events. Experiments were pursued to examine the potential of Epi to stimulate myocardial angiogenesis and determine the effects that its combined use with exercise (Ex) may trigger. Hearts obtained from a previous study were used for this purpose. Animals received 1 mg/kg of Epi or water (vehicle) via oral gavage (twice daily). Epi and/or Ex (by treadmill) was provided for 15 days. Results indicate that Ex or Epi significantly stimulate myocardial angiogenesis by ∼30% above control levels. The use of Epi-Ex lead to further significant increases (to ∼50%). Effects were associated with increases in protein levels and/or activation of canonical angiogenesis pathway associated events (HIF1a, VEGF, VEGFR2, PI3K, PDK, AKT, eNOS, NO, cGMP, MMP-2/-9, Src-1, and CD31). Thus, the use of Epi may represent a safe and novel means to stimulate myocardial angiogenesis.

[1]  R. Coral-Vázquez,et al.  Caveolae and non-caveolae lipid raft microdomains of human umbilical vein endothelial cells contain utrophin-associated protein complexes. , 2012, Biochimie.

[2]  G. Perkins,et al.  (–)‐Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle , 2011, The Journal of physiology.

[3]  F. Lallemand,et al.  Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure , 2011, Circulation.

[4]  O. Franco,et al.  Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis , 2011, BMJ : British Medical Journal.

[5]  L. Ferrucci,et al.  Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. , 2011, JAMA.

[6]  C. Kwik-Uribe,et al.  The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. , 2011, Free radical biology & medicine.

[7]  F. Villarreal,et al.  (-)-Epicatechin induces calcium and translocation independent eNOS activation in arterial endothelial cells. , 2011, American journal of physiology. Cell physiology.

[8]  I. Zachary,et al.  Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects , 2010, Heart.

[9]  A. Wolk,et al.  Chocolate Intake and Incidence of Heart Failure: A Population-Based Prospective Study of Middle-Aged and Elderly Women , 2010, Circulation. Heart failure.

[10]  S. Glantz,et al.  Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. , 2010, Journal of the American College of Cardiology.

[11]  A. Zambon,et al.  Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion. , 2010, Journal of the American College of Cardiology.

[12]  F. Villarreal,et al.  (−)-Epicatechin Activation of Endothelial Cell Endothelial Nitric Oxide Synthase, Nitric Oxide, and Related Signaling Pathways , 2010, Hypertension.

[13]  H. Elewa,et al.  Diverse Effects of Statins on Angiogenesis: New Therapeutic Avenues , 2010, Pharmacotherapy.

[14]  T. Lüscher,et al.  Cocoa and Cardiovascular Health , 2009, Circulation.

[15]  F. Villarreal,et al.  Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. , 2008, American journal of physiology. Heart and circulatory physiology.

[16]  F. Rengo,et al.  Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. , 2008, Cardiovascular research.

[17]  J. Huot,et al.  Endothelial cell migration during angiogenesis. , 2007, Circulation research.

[18]  M. McCullough,et al.  Hypertension, the Kuna, and the Epidemiology of Flavanols , 2006, Journal of cardiovascular pharmacology.

[19]  N. Hollenberg,et al.  (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Maulik,et al.  Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1 , 2006, Cell Biochemistry and Biophysics.

[21]  Steven P Jones,et al.  The ubiquitous role of nitric oxide in cardioprotection. , 2006, Journal of molecular and cellular cardiology.

[22]  C. Bloor Angiogenesis during exercise and training , 2005, Angiogenesis.

[23]  N. Maulik,et al.  Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. , 2005, Journal of molecular and cellular cardiology.

[24]  N. Hollenberg,et al.  Flavanols for cardiovascular health: the science behind the sweetness , 2005, Journal of hypertension.

[25]  B. Gigante,et al.  Placenta growth factor is not required for exercise-induced angiogenesis , 2004, Angiogenesis.

[26]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[27]  C. Murry,et al.  Immunohistologic labeling of murine endothelium. , 2003, Cardiovascular pathology.

[28]  K. Kuck,et al.  Erythropoietin and VEGF exhibit equal angiogenic potential. , 2002, Microvascular research.

[29]  C. Bloor,et al.  Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. , 1998, Journal of applied physiology.

[30]  H. Granger,et al.  Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.

[31]  P. Wagner,et al.  Determinants of maximal oxygen transport and utilization. , 1996, Annual review of physiology.

[32]  S Amerini,et al.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.

[33]  S. Egginton,et al.  Angiogenesis in skeletal and cardiac muscle. , 1992, Physiological reviews.